Post Reports

With $270 million settlement, Purdue Pharma starts paying for the opioid crisis

Katie Zezima on the pharmaceutical company’s landmark settlement. Amy Gardner on voting rights for felons in Florida. And Dan Zak on butterflies and the border wall.
Listen for free

About Post Reports

Post Reports is the daily podcast from The Washington Post. Unparalleled reporting. Expert insight. Clear analysis. Everything you’ve come to expect from the newsroom of The Post -- for your ears.

In this episode

Purdue Pharma settles Oklahoma opioid suit
On Tuesday, Purdue Pharma agreed to settle a lawsuit with the state of Oklahoma for $270 million. The lawsuit centered on the OxyContin creator’s role in the opioid crisis, with the payout largely going to fund a new center at the University of Oklahoma to study and treat addiction and pain.

Katie Zezima details how the Purdue Pharma settlement could potentially “set the floor” for settlements in the thousands of other lawsuits leveled against pharmaceutical companies over the deadly opioid epidemic.

More on this topic:

Felon voting rights in Florida may face restrictions
Last midterms, Florida voters overwhelmingly approved a ballot measure that would allow felons to vote. Now, Republicans say there should be implementation legislation that goes along with it.

Amy Gardner covers voting issues for The Post and says the number of eligible felons — as many as 1.4 million Floridians — may dwindle if the Republican-held Florida legislature limits Amendment 4’s scope. Democrats are crying foul as Republicans insist they are merely fleshing out a vague and sparse amendment.

More on this topic:

Monarch butterflies take on a new symbolism
Features writer Dan Zak went to the southern border to understand how partisan battles over immigration are affecting the plight of monarch butterflies.

More on this topic:

About Post Reports

Post Reports is the daily podcast from The Washington Post. Unparalleled reporting. Expert insight. Clear analysis. Everything you’ve come to expect from the newsroom of The Post -- for your ears.